2.2 пъти е ръстът на украинските туристи през юли 2024.
2.2 пъти е ръстът на украинските туристи през юли 2024 спрямо юли 2023 година. Приложение 1 Спрямо същия месец на 2022 година ръстът е близо 3 пъти. Забележете говорим само…
Timbercreek Financial Declares September 2024 Dividend
TORONTO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share…
Clover Leaf Capital Corp. Announces Adjournment of Special Meeting of Stockholders on Proposed Business Combination
MIAMI, FL and KANSAS CITY, KS, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Clover Leaf Capital Corp. (Nasdaq: CLOE) (“CLOE” or “Clover Leaf”), a publicly traded special purpose acquisition company, and…
Moody’s hækkar lánshæfiseinkunn Íslands í A1 með stöðugum horfum
Lánshæfismatsfyrirtækið Moody's Ratings (Moody's) hækkaði í dag lánshæfiseinkunnir íslenska ríkisins í innlendum og erlendum gjaldmiðlum í A1 úr A2. Horfur fyrir einkunnina eru stöðugar. Helsti drifkrafturinn fyrir hækkun lánshæfismatsins er…
Moody’s Ratings upgrades Iceland’s ratings to A1, changes outlook to stable
Moody’s Ratings (Moody's) has upgraded the local and foreign-currency long-term issuer ratings of the Government of Iceland to A1 from A2 and changed the outlook to stable from positive. The…
BULGOLD Provides an Update on the Lutila Gold Project
TORONTO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to provide a progress update on its Lutila Gold Project located in Central…
Verses AI Inc. Announces LIFE Private Placement Offering up to C$10,000,000
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE:…
Mobile-health Network Solutions Delinquency Notification Letter From Nasdaq
SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received a notice dated September…
Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant Approval based on…
Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué (…)
Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué, non éligibles à une transplantation Approbation fondée…